Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Lisdexamfetamine 50mg capsules |
| BNF code | 0404000U0AAADAD |
| Virtual Therapeutic Moiety | Lisdexamfetamine |
| Date identifier became valid | 3 Jul 2023 |
| Previous product identifier | 426412009 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Lisdexamfetamine dimesylate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 50.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Date of applicability | 10 Jun 2014 |
| Previous Controlled Drug information | No Controlled Drug Status |
| Actual Medicinal Products | |
| Elvanse 50mg capsules (CST Pharma Ltd) | |
| Elvanse 50mg capsules (Pilsco Ltd) | |
| Elvanse 50mg capsules (Takeda UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Lisdexamfetamine 50mg capsules 100 capsule | |
| Lisdexamfetamine 50mg capsules 28 capsule | |
| Lisdexamfetamine 50mg capsules 30 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20251124000001, imported on 25th November 2025 at 04:18:46.